Fong Clow
Fong Clow publishes mostly in Genetics, Pathology and Forensic Medicine and Hematology, on topics such as Chronic Lymphocytic Leukemia Research, Lymphoma Diagnosis and Treatment and Chronic Myeloid Leukemia Treatments.
- World rank
- #405,967 of 7,710,434 ranked researchers
- Rank in United States
- #143,882 of 1,627,098
- Works
- 48
- Citations
- 13k
- Citations per work
- 264.3
What does Fong Clow research?
Fong Clow's work is mostly in Medicine (76%), Immunology and Microbiology (8%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences3776.4%
- Medicine3776.4%
- Everything else715.5%
- Life Sciences48.1%
- 1Genetics33% of their works
- 2Pathology and Forensic Medicine24% of their works
- 3Hematology12% of their works
- 4Immunology8% of their works
- 5Gastroenterology5% of their works
- 6Oncology3% of their works
Research topics
- Chronic Lymphocytic Leukemia Research
- Lymphoma Diagnosis and Treatment
- Chronic Myeloid Leukemia Treatments
- Gastrointestinal Tumor Research and Treatment
- Phagocytosis and Immune Regulation
- Immunodeficiency and Autoimmune Disorders
- Acute Lymphoblastic Leukemia research
- Multiple Myeloma Research and Treatments
Which keywords describe Fong Clow's research?
The keywords of their largest research topics: Rituximab, Prognostic Factors, Chronic Lymphocytic Leukemia, Genomic Aberrations, PET Imaging, Classification, Lymphoma and BCR-ABL.
- International Myeloma Working Group
- Primary Immunodeficiency
- Childhood Cancer
- apoptotic cells
- Sunitinib
- Imatinib Mesylate
- BCR-ABL
- Classification
- Genomic Aberrations
- Prognostic Factors
- Rituximab
- Chronic Lymphocytic Leukemia
- PET Imaging
- Lymphoma
- Imatinib
- Minimal Residual Disease
- CD47
- Acute Lymphoblastic Leukemia
- Genetic Mutations
- Diagnosis Criteria
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Rituximab762 topics
- Prognostic Factors553 topics
- Chronic Lymphocytic Leukemia441 topic
- Genomic Aberrations441 topic
- PET Imaging392 topics
- Classification321 topic
- Lymphoma321 topic
- BCR-ABL131 topic
- Imatinib131 topic
- Imatinib Mesylate71 topic
- Minimal Residual Disease72 topics
- Sunitinib71 topic
- CD4751 topic
- apoptotic cells51 topic
- Acute Lymphoblastic Leukemia41 topic
- Childhood Cancer41 topic
- Genetic Mutations41 topic
- Primary Immunodeficiency41 topic
- Diagnosis Criteria31 topic
- International Myeloma Working Group31 topic
Where does Fong Clow work?
Fong Clow's main affiliation in the publication record is Pharmacyclics (United States), United States.
How many publications and citations does Fong Clow have?
OpenAlex counts 48 works and 12,687 citations for Fong Clow, an h-index of 26, ranking #405,967 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Fong Clow. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.